Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Grigory BolotnikovInstitute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany.
Daniel GruberInstitute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany.ORCID 0009-0007-7142-1039
Jan-Christoph WalterInstitute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany.
Kim KühnelInstitute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany.
Turgay KemalInstitute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany.
Armando RodriguezCore Facility for Functional Peptidomics (CFP), Faculty of Medicine, Ulm University, 89081 Ulm, Germany.ORCID 0000-0001-5921-3770
Nico PreisingCore Facility for Functional Peptidomics (CFP), Faculty of Medicine, Ulm University, 89081 Ulm, Germany.
Ludger StändkerCore Facility for Functional Peptidomics (CFP), Faculty of Medicine, Ulm University, 89081 Ulm, Germany.ORCID 0000-0002-8436-4260
Carolina FiracativeStudies in Translational Microbiology and Emerging Diseases (MICROS) Research Group, School of Medicine and Health Sciences, Universidad de Rosario, Bogota 111221, Colombia.ORCID 0000-0001-7547-5172
Barbara SpellerbergInstitute for Medical Microbiology and Hygiene, University Hospital Ulm, 89081 Ulm, Germany.ORCID 0000-0001-7552-8764
Steffen StengerInstitute for Medical Microbiology and Hygiene, University Hospital Ulm, 89081 Ulm, Germany.
Frank RosenauInstitute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany.ORCID 0000-0002-9297-6419
Anschubfinanzierung A 2025 of Ulm University A 2025Austrian Research Promotion Agency (FFG) 915477Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) 465229237Förderstelle Wirtschaft, Tourismus und Technologie (WST) WST-F-5035462/004-2024Gesellschaft für Forschungsförderung (GFF) of Lower Austria FTI22-G-012
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Phage Display-Derived Peptides Have Neutralizing Activities Against Biofilm Formation by · full record | OpenQuestion